Session » Fibromyalgia & Other Clinical Pain Syndromes Poster

Date: Sunday, November 10, 2019

Time: 9:00AM-11:00AM

Meeting: 2019 ACR/ARP Annual Meeting

9:00AM-11:00AM: Abstract Number: 219

A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI

9:00AM-11:00AM: Abstract Number: 224

A Functional Exercise Program Improves Pain and Health Related Quality of Life in Patients with Fibromyalgia: A Randomized Controllel Trial

9:00AM-11:00AM: Abstract Number: 220

A Positive Response to Nonpharmacological Therapies in Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 222

Acupuncture for Chronic Musculoskeletal Pain: A Review of Randomized Controlled Trials

9:00AM-11:00AM: Abstract Number: 241

Comparing Patients with Fibromyalgia Syndrome with Non-Fibromyalgia Rheumatic Disease Patients Regarding Exercise

9:00AM-11:00AM: Abstract Number: 243

Concomitant Fibromyalgia in Patients with Other Rheumatic Diseases and Response to Treatment

9:00AM-11:00AM: Abstract Number: 223

Correlation Between Heart Rate Variability Parameters and Circulating Neuropeptides in Fibromyalgia

9:00AM-11:00AM: Abstract Number: 237

Determination of Muscle Pressure in Patients with Fibromyalgia by Two Examiners; The Examiners Get Similar Results

9:00AM-11:00AM: Abstract Number: 216

Does Fibromyalgia Change the Evaluation of Spondyloarthritis Activity? A Meta-analysis of Observational Studies

9:00AM-11:00AM: Abstract Number: 231

Duloxetine for Chronic Pain Management in a Tertiary Care Rheumatology Practice: How Patients Are Doing in the Real World

9:00AM-11:00AM: Abstract Number: 211

Effects of Deep Haptic Massage in Fibromyalgia (pilot Study)

9:00AM-11:00AM: Abstract Number: 218

Effects of Tai Chi versus Aerobic Exercise on Mindfulness in Fibromyalgia

9:00AM-11:00AM: Abstract Number: 221

Emergency Department Utilization for Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 225

Evaluating Fibromyalgia Symptoms in Transgender Patients

9:00AM-11:00AM: Abstract Number: 217

Fibromyalgia and Multiple Switching of Biologics in Spondylarthritis

9:00AM-11:00AM: Abstract Number: 228

Good Pain, Bad Pain: Illness Perception and Physicians Attitude Towards Rheumatoid Arthritis and Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 232

Hand Digital Thermography Findings in Patients with Primary Fibromyalgia

9:00AM-11:00AM: Abstract Number: 214

How Well Do Visual Analogue Scales Used in the Fibromyalgia Impact Questionnaire (FIQ) Correlate with Other Measures of Pain, Fatigue, Sleep, Sleep Disturbance, Anxiety and Depression in Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 226

Hypersensitivity Beyond Pain: Hyperacusis and Hyperalgesia of Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 233

Intensive CBT Is Effective in the Treatment of Significant Functional Impairment and Psychological Distress Found in Fibromyalgia: But Can We Improve Depressive Symptoms?

9:00AM-11:00AM: Abstract Number: 229

Is Fibromyalgia Associated with Structural or Functional Abnormalities in Skeletal Muscle?

9:00AM-11:00AM: Abstract Number: 227

Metabolomic and Symptom Comparison in Women With/without Fibromyalgia: A Pilot Study

9:00AM-11:00AM: Abstract Number: 238

Muscle Pressure as Measured by a Manometer Correlates with Dolorimetry in Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 235

Muscle Pressure Correlates with Pain Levels in Fibromyalgia Patients and Muscle Tension May Be the Cause of Their Pain

9:00AM-11:00AM: Abstract Number: 215

Opioid Treatment Pattern in a Community Based Rheumatology Clinic

9:00AM-11:00AM: Abstract Number: 234

Oxytocin Attenuates Tactile Allodynia in Experimental Fibromyalgia Rats

9:00AM-11:00AM: Abstract Number: 230

Patients with Fibromyalgia Associated with Rheumatoid Arthritis and Patients with Primary Fibromyalgia Differ in Depression, Anxiety, Stress-related Disorders and Events: A Cross-sectional Study

9:00AM-11:00AM: Abstract Number: 213

Relationship Between a History of Abuse and Fibromyalgia Symptoms and Severity: Data from the Cleveland Clinic Fibromyalgia Registry

9:00AM-11:00AM: Abstract Number: 236

Repeat Muscle Pressures Measured in Fibromyalgia Patients and Compared with Pain Scores

9:00AM-11:00AM: Abstract Number: 242

The Effectiveness of Medications for Fibromyalgia Based on Patient Experiences

9:00AM-11:00AM: Abstract Number: 239

The SELENA SLEDAI Is an Imperfect Measure of Lupus Disease Activity in Patients with Concomitant Fibromyalgia

9:00AM-11:00AM: Abstract Number: 212

Utility of Mood Disorders Questionnaire in Fibromyalgia: Data from the Cleveland Clinic Fibromyalgia Registry

9:00AM-11:00AM: Abstract Number: 240

Whom Do Patients with Fibromyalgia Turn to for Emotional Support?

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].